Using anti-estrogens as well as HSPE inhibitors developed for cancer treatment and in use in clinical trials, and the SDC1 specific inhibitor SSTN, we investigated their effects in patient-derived explants of normal mammary tissue cultured over a 2 week period. The gene discussed is SDC1; the disease is cancer.